Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase

Kathryn Martin Remington, Ya Qi Zhu, Tom R. Phillips, Thomas W. North

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We have selected and plaque purified zidovudine (3'-azido-3'- deoxythymidine [AZT])-resistant mutants from an infectious molecular clone of feline immunodeficiency virus (FIV). The patterns of cross-resistance and drug susceptibilities of these mutants were similar to those of the AZT- resistant FIV that we previously selected in vitro from a wild-type FIV population and to those of the most common AZT-resistant clinical isolates of human immunodeficiency virus type 1. Two AZT-resistant mutants of FIV, one selected from a normal population and one selected from the molecular clone, each reverted rapidly to an AZT-sensitive phenotype when passaged in the absence of drug. Sequence analysis of the reverse transcriptase (RT)-encoding region from the plaque-purified AZT-resistant FIV revealed a single base change at position 2939, resulting in a Glu-to-Lys substitution at amino acid 202 of the RT. Similar analyses of plaque-purified revertants showed that the phenotypic reversion was not the result of a genotypic reversion at this position and that no additional mutations existed within the RT-encoding region of the revertants. Moreover, RTs purified from the mutant and revertant were both resistant to the 5'-triphosphate of AZT. These results indicate the complexity of AZT resistance and suggest the presence of additional factors, outside the RT-encoding region, which may contribute to AZT resistance.

Original languageEnglish (US)
Pages (from-to)632-637
Number of pages6
JournalJournal of Virology
Volume68
Issue number2
StatePublished - Feb 1994
Externally publishedYes

Fingerprint

Feline Immunodeficiency Virus
Feline immunodeficiency virus
Zidovudine
RNA-directed DNA polymerase
RNA-Directed DNA Polymerase
drugs
mutants
Pharmaceutical Preparations
Clone Cells
clones
cross resistance
Amino Acid Substitution
Human immunodeficiency virus 1
Drug Resistance
Population
Sequence Analysis
HIV-1
sequence analysis
Phenotype
mutation

ASJC Scopus subject areas

  • Immunology

Cite this

Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase. / Remington, Kathryn Martin; Zhu, Ya Qi; Phillips, Tom R.; North, Thomas W.

In: Journal of Virology, Vol. 68, No. 2, 02.1994, p. 632-637.

Research output: Contribution to journalArticle

Remington, Kathryn Martin ; Zhu, Ya Qi ; Phillips, Tom R. ; North, Thomas W. / Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase. In: Journal of Virology. 1994 ; Vol. 68, No. 2. pp. 632-637.
@article{ce5a15565a02467ba9c6d820e696df9b,
title = "Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase",
abstract = "We have selected and plaque purified zidovudine (3'-azido-3'- deoxythymidine [AZT])-resistant mutants from an infectious molecular clone of feline immunodeficiency virus (FIV). The patterns of cross-resistance and drug susceptibilities of these mutants were similar to those of the AZT- resistant FIV that we previously selected in vitro from a wild-type FIV population and to those of the most common AZT-resistant clinical isolates of human immunodeficiency virus type 1. Two AZT-resistant mutants of FIV, one selected from a normal population and one selected from the molecular clone, each reverted rapidly to an AZT-sensitive phenotype when passaged in the absence of drug. Sequence analysis of the reverse transcriptase (RT)-encoding region from the plaque-purified AZT-resistant FIV revealed a single base change at position 2939, resulting in a Glu-to-Lys substitution at amino acid 202 of the RT. Similar analyses of plaque-purified revertants showed that the phenotypic reversion was not the result of a genotypic reversion at this position and that no additional mutations existed within the RT-encoding region of the revertants. Moreover, RTs purified from the mutant and revertant were both resistant to the 5'-triphosphate of AZT. These results indicate the complexity of AZT resistance and suggest the presence of additional factors, outside the RT-encoding region, which may contribute to AZT resistance.",
author = "Remington, {Kathryn Martin} and Zhu, {Ya Qi} and Phillips, {Tom R.} and North, {Thomas W.}",
year = "1994",
month = "2",
language = "English (US)",
volume = "68",
pages = "632--637",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase

AU - Remington, Kathryn Martin

AU - Zhu, Ya Qi

AU - Phillips, Tom R.

AU - North, Thomas W.

PY - 1994/2

Y1 - 1994/2

N2 - We have selected and plaque purified zidovudine (3'-azido-3'- deoxythymidine [AZT])-resistant mutants from an infectious molecular clone of feline immunodeficiency virus (FIV). The patterns of cross-resistance and drug susceptibilities of these mutants were similar to those of the AZT- resistant FIV that we previously selected in vitro from a wild-type FIV population and to those of the most common AZT-resistant clinical isolates of human immunodeficiency virus type 1. Two AZT-resistant mutants of FIV, one selected from a normal population and one selected from the molecular clone, each reverted rapidly to an AZT-sensitive phenotype when passaged in the absence of drug. Sequence analysis of the reverse transcriptase (RT)-encoding region from the plaque-purified AZT-resistant FIV revealed a single base change at position 2939, resulting in a Glu-to-Lys substitution at amino acid 202 of the RT. Similar analyses of plaque-purified revertants showed that the phenotypic reversion was not the result of a genotypic reversion at this position and that no additional mutations existed within the RT-encoding region of the revertants. Moreover, RTs purified from the mutant and revertant were both resistant to the 5'-triphosphate of AZT. These results indicate the complexity of AZT resistance and suggest the presence of additional factors, outside the RT-encoding region, which may contribute to AZT resistance.

AB - We have selected and plaque purified zidovudine (3'-azido-3'- deoxythymidine [AZT])-resistant mutants from an infectious molecular clone of feline immunodeficiency virus (FIV). The patterns of cross-resistance and drug susceptibilities of these mutants were similar to those of the AZT- resistant FIV that we previously selected in vitro from a wild-type FIV population and to those of the most common AZT-resistant clinical isolates of human immunodeficiency virus type 1. Two AZT-resistant mutants of FIV, one selected from a normal population and one selected from the molecular clone, each reverted rapidly to an AZT-sensitive phenotype when passaged in the absence of drug. Sequence analysis of the reverse transcriptase (RT)-encoding region from the plaque-purified AZT-resistant FIV revealed a single base change at position 2939, resulting in a Glu-to-Lys substitution at amino acid 202 of the RT. Similar analyses of plaque-purified revertants showed that the phenotypic reversion was not the result of a genotypic reversion at this position and that no additional mutations existed within the RT-encoding region of the revertants. Moreover, RTs purified from the mutant and revertant were both resistant to the 5'-triphosphate of AZT. These results indicate the complexity of AZT resistance and suggest the presence of additional factors, outside the RT-encoding region, which may contribute to AZT resistance.

UR - http://www.scopus.com/inward/record.url?scp=0028012038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028012038&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 632

EP - 637

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 2

ER -